ResMed Inc. Common Stock (NY:RMD)

218.89 -2.26 (-1.02%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

2 Reasons to Watch RMD and 1 to Stay Cautious

July 15, 2025

ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 5.4%.

Via StockStory

Topics Government Stocks

Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗

July 11, 2025

Via The Motley Fool

2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear Of

July 09, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Economy Stocks

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

July 01, 2025

From Resmed, Inc.

Via GlobeNewswire

RESMED INC (NYSE:RMD) – A Strong Candidate for Quality Investors ↗

July 01, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional ROIC, and solid cash flow, making it a standout pick for long-term investors.

Via Chartmill

2 Cash-Producing Stocks to Consider Right Now and 1 to Ignore

June 19, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Looking Back on a Motley Fool Career ↗

June 17, 2025

Via The Motley Fool

ResMed: A Mixed Bag for Investors Amid Rising Competition ↗

June 10, 2025

Via The Motley Fool

RESMED INC (NYSE:RMD) – A Strong Contender for Quality Investors ↗

June 09, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors.

Via Chartmill

2 Large-Cap Stocks with Competitive Advantages and 1 to Approach with Caution

June 09, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Topics Fraud

3 Cash-Heavy Stocks with Competitive Advantages

June 06, 2025

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. Without interest payments being less of a worry, these businesses can invest...

Via StockStory

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

June 02, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

1 Surging Stock with Exciting Potential and 2 to Avoid

May 23, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved ↗

May 20, 2025

RBC Capital noted that ResMed now has “a number of competitive threats on the horizon."

Via Stocktwits

Topics Government

What's going on in today's pre-market session: S&P500 movers ↗

May 20, 2025

Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.

Via Chartmill

May 20, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

RESMED INC (NYSE:RMD) – A Quality Stock with Strong Fundamentals ↗

May 19, 2025

RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional profitability, and a solid balance sheet, making it a standout pick for long-term investors.

Via Chartmill

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

May 18, 2025

Via The Motley Fool

Topics Retirement

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 15, 2025

From Resmed, Inc.

Via GlobeNewswire

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

May 14, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst...

Via StockStory

Topics Artificial Intelligence

3 Profitable Stocks to Consider Right Now

May 06, 2025

Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting...

Via StockStory

Resmed Acquires VirtuOx

May 01, 2025

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers

From Resmed, Inc.

Via GlobeNewswire

What's going on in today's session: S&P500 gap up and gap down stocks ↗

April 28, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.

Via Chartmill

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

April 26, 2025

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with...

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

April 24, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast ↗

April 24, 2025

ResMed posted Q3 EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions.

Via Benzinga

Topics World Trade

What's going on in today's session: S&P500 movers ↗

April 24, 2025

Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 24, 2025

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

April 24, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday? ↗

April 24, 2025

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...

Via Benzinga

Topics Government World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.